Hyderabad Telangana, India

Vijaya Krishna Ravi

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Mylan Laboratories Limited. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijaya Krishna Ravi. Retrieved from https://idiyas.com/inventor/vijaya-krishna-ravi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2015-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vijaya Krishna Ravi: Innovator in Pharmaceutical Patents

Introduction

Vijaya Krishna Ravi is a prominent inventor based in Hyderabad, Telangana, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug formulations. With a total of four patents to her name, her work has had a substantial impact on the industry.

Latest Patents

Among her latest patents is the development of polymorphic forms of sofosbuvir. This patent provides a novel crystalline sofosbuvir form-M3 and outlines a process for its preparation. The crystalline sofosbuvir form-M3 may be useful in the formulation of pharmaceutical dosage forms. Additionally, she has patented a process for the preparation of intermediates useful in the synthesis of sofosbuvir, which includes intermediates of formula [12].

Career Highlights

Vijaya Krishna Ravi is currently employed at Mylan Laboratories Limited, where she continues to innovate and contribute to pharmaceutical research. Her expertise in drug formulation and synthesis has positioned her as a key player in her field.

Collaborations

She has collaborated with notable coworkers, including Vipin Kumar Kaushik and Srinivas Vakiti, to advance her research and patent applications.

Conclusion

Vijaya Krishna Ravi's contributions to pharmaceutical innovations through her patents exemplify her dedication to improving drug formulations. Her work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…